| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |